Top compounds associated with response to TLL2


Feature Type Standardized
Nominal ANOVA
mRNA AEW541 CCLE pan-cancer AAC -0.035 0.5
mRNA Sunitinib CTRPv2 pan-cancer AAC -0.027 0.5
mRNA NSC-87877 GDSC1000 pan-cancer AAC -0.026 0.5
mRNA Crizotinib CCLE pan-cancer AAC -0.035 0.5
mRNA Nilotinib CTRPv2 pan-cancer AAC 0.029 0.5
mRNA PI-103 CTRPv2 pan-cancer AAC 0.028 0.5
mRNA alisertib CTRPv2 pan-cancer AAC -0.025 0.5
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.027 0.5
mRNA SN-38 GDSC1000 pan-cancer AAC -0.024 0.5
mRNA apicidin CTRPv2 pan-cancer AAC -0.024 0.5
Download CSV